Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 211769
Company: GLENMARK PHARMS LTD
Company: GLENMARK PHARMS LTD
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PIMECROLIMUS | PIMECROLIMUS | 1% | CREAM;TOPICAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/29/2019 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
PIMECROLIMUS
CREAM;TOPICAL; 1%
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ELIDEL | PIMECROLIMUS | 1% | CREAM;TOPICAL | Prescription | Yes | AB | 021302 | BAUSCH |
PIMECROLIMUS | PIMECROLIMUS | 1% | CREAM;TOPICAL | Prescription | No | AB | 209345 | ACTAVIS LABS UT INC |
PIMECROLIMUS | PIMECROLIMUS | 1% | CREAM;TOPICAL | Prescription | No | AB | 211769 | GLENMARK PHARMS LTD |